Corynebacterium striatum prosthetic valve endocarditis with severe aortic regurgitation successfully treated with transcatheter aortic valve replacement

Department

Internal Medicine

Document Type

Article

Publication Title

BMJ Case Reports

Abstract

We describe the case of a 69-year-old man with a history of bioprosthetic aortic valve replacement who presented with Corynebacterium striatum prosthetic valve endocarditis (PVE) complicated by severe aortic insufficiency with refractory cardiogenic shock despite antibiotic therapy. He was considered a prohibitive-risk surgical candidate due to co-morbid conditions and off-label valve-in-valve transcatheter aortic valve replacement (TAVR) was performed after detailed multidisciplinary evaluation. He recovered well without recurrent infection following completion of antibiotics and transthoracic echocardiogram at 12 months showed a normal functioning prosthetic valve. To our knowledge, this is the first reported case of native or PVE treated with TAVR.

DOI

10.1136/bcr-2018-226881

Volume

11

Issue

1

Publication Date

11-28-2018

Medical Subject Headings

Aged; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Insufficiency; Corynebacterium; Endocarditis; Endocarditis, Bacterial; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Transcatheter Aortic Valve Replacement; Treatment Outcome

PubMed ID

30567113

Link to Full Text

Share

COinS